ELFBAR Launches Magnetic Pod Vape EW9000 with Striking Resemblance to Off Stamp SW9000

Elfbar by 2FIRSTS, edited by Sophia
Apr.30.2024
ELFBAR Launches Magnetic Pod Vape EW9000 with Striking Resemblance to Off Stamp SW9000
CISION released a press release on 29 April, mentioning ELFBAR's launch of e-cigarette EW9000 in Canada, Latin America, and UAE markets.

On April 29th, 2FIRSTS noticed that the foreign media outlet CISION had published an article suspected to be a PR piece for ELFBAR. The article mentioned that ELFBAR has launched a new e-cigarette product, the EW9000, in the markets of Canada, Latin America, and the United Arab Emirates.

 

ELFBAR Launches Magnetic Pod Vape EW9000 with Striking Resemblance to Off Stamp SW9000
Article released on the CISION platform about ELFBAR launching a new product | Image source: CISION

 

The article mentions that the EW9000 includes two magnetic components: a disposable replaceable pod and an 820mAh rechargeable device, which are connected via magnetic attraction, designed to support up to 9000 puffs. This magnetic design allows users to retain and reuse the rechargeable device when replacing the disposable pod, thereby extending the product's lifespan.

 

ELFBAR Launches Magnetic Pod Vape EW9000 with Striking Resemblance to Off Stamp SW9000
ELFBAR EW9000 | Image source: ELFBAR official website

 

An investigation by 2FIRSTS has revealed that the appearance of the EW9000 is extremely similar to the SW9000 product released in the US market by the Off Stamp brand at the end of 2023, with the main difference being the branding labels used.

 

ELFBAR Launches Magnetic Pod Vape EW9000 with Striking Resemblance to Off Stamp SW9000
Off Stamp SW9000 | Image source: US distributor website

 

The Off Stamp SW9000 is only available in the United States, with the logo "Off Stamp" printed on the side of the product; while the ELFBAR EW9000 is launched in the Canadian, Latin American, and Middle Eastern markets, with the logo "ELFBAR" printed on the side of the product.

 

ELFBAR Launches Magnetic Pod Vape EW9000 with Striking Resemblance to Off Stamp SW9000
Comparison chart of Off Stamp SW9000 and ELFBAR EW9000

 

It is worth noting that ELFBAR was banned from entering the US market last year due to trademark issues and an import alert issued by the FDA. ELFBAR has stated in interviews that as of May 2023, both ELFBAR and EBDESIGN have stopped supplying products to the United States.

 

2FIRSTS will continue to track and report on this event. Please stay tuned.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06